Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 0.50 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.49 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.49 |
| ▸ | CACNA1I | Q9P0X4 | 2/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14747606 | 0.91 | PTGS2 (0.51) | PTGS2CACNA1GCACNA1HCACNA1IPTGS1 | |
| SCHEMBL6351481 | 0.85 | PTGS2 (0.73) | PTGS2PTGS1 | |
| SCHEMBL3379848 | 0.82 | CACNA1G (0.39) | PTGS2CACNA1GCACNA1HCACNA1IPTGS1 | |
| SCHEMBL11248247 | 0.81 | KMT2A (0.49) | PTGS2CACNA1GCACNA1HCACNA1IPTGS1 | |
| SCHEMBL3383520 | 0.81 | BRAF (0.43) | PTGS2PTGS1SMN1; SMN2 | |
| SCHEMBL14747809 | 0.78 | PTGS2 (0.71) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL8689175 | 0.78 | F10 (0.49) | PTGS2PTGS1 | |
| SCHEMBL14747815 | 0.77 | PTGS2 (0.54) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL538098 | 0.75 | CACNA1G (0.35) | PTGS2CACNA1GCACNA1HCACNA1IPTGS1 | |
| SCHEMBL14747799 | 0.72 | PTGS2 (0.47) | PTGS2PTGS1CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE44048-E1 | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder | G.D. SEARLE LLC (US) | 2013-03-05 | — | — | US | disclosed |